Title:
CRYSTAL FORM OF COMPOUND
Document Type and Number:
WIPO Patent Application WO/2018/099451
Kind Code:
A1
Abstract:
The present invention belongs to the field of pharmacy and provides a crystal form of a compound (3aR,6aR)-N-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yl)-1-methyl-hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxamide, a pharmaceutical composition thereof, and a preparation method therefor and the use thereof.
Inventors:
WU ZHENPING (CN)
LI WENJI (CN)
CHU YUPING (CN)
LI WENJI (CN)
CHU YUPING (CN)
Application Number:
PCT/CN2017/114194
Publication Date:
June 07, 2018
Filing Date:
December 01, 2017
Export Citation:
Assignee:
HUTCHISON MEDIPHARMA LTD (CN)
International Classes:
C07D487/04; A61K31/517; A61P35/00; A61P35/02
Foreign References:
| CN102906086A | 2013-01-30 | |||
| CN102311438A | 2012-01-11 |
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF: